Exact Mass: 514.1951

Exact Mass Matches: 514.1951

Found 23 metabolites which its exact mass value is equals to given mass value 514.1951, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Nb-trans-Feruloylserotonin glucoside

(2E)-3-(4-Hydroxy-3-methoxyphenyl)-N-[2-(5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1H-indol-3-yl)ethyl]prop-2-enimidate

C26H30N2O9 (514.1951)

Nb-trans-Feruloylserotonin glucoside is found in fats and oils. Nb-trans-Feruloylserotonin glucoside is an alkaloid from Carthamus tinctorius (safflower). Alkaloid from Carthamus tinctorius (safflower). Nb-trans-Feruloylserotonin glucoside is found in fats and oils and herbs and spices.

Nb-trans-Feruloylserotonin glucoside

(2E)-3-(4-hydroxy-3-methoxyphenyl)-N-[2-(5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1H-indol-3-yl)ethyl]prop-2-enamide

C26H30N2O9 (514.1951)

(3S,7R)-8-benzyl-3-{[(3-hydroxy-4-methoxypyridin-2-yl)carbonyl]amino}-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl 2-methylpropanoate

C26H30N2O9 (514.1951)

UK-2A

C26H30N2O9 (514.1951)

A lactone which is 9-methyl-1,5-dioxonane-2,6-dione substituted by a benzyl group at position 8, a [(3-hydroxy-4-methoxypyridine-2-yl)carbonyl]amino group at position 3 and an isobutyryloxy group at position 7. It is isolated from the mycelia cake of Streptomyces sp. 517-02 and exhibits potent antifungal activity.

(1s,18s,19r,20s)-19-ethenyl-7-hydroxy-18-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15-pentaen-14-one

(1s,18s,19r,20s)-19-ethenyl-7-hydroxy-18-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15-pentaen-14-one

C26H30N2O9 (514.1951)

(4s,5s,6r)-5-ethenyl-4-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-6-{[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C26H30N2O9 (514.1951)

10-hydroxystrictosamide

C26H30N2O9 (514.1951)

{"Ingredient_id": "HBIN000156","Ingredient_name": "10-hydroxystrictosamide","Alias": "NA","Ingredient_formula": "C26H30N2O9","Ingredient_Smile": "C=CC1C2CC3C4=C(CCN3C(=O)C2=COC1OC5C(C(C(C(O5)CO)O)O)O)C6=C(N4)C=CC(=C6)O","Ingredient_weight": "514.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10732","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "70675008","DrugBank_id": "NA"}

19-ethenyl-7-hydroxy-18-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15-pentaen-14-one

C26H30N2O9 (514.1951)

(6s)-5-ethenyl-4-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C26H30N2O9 (514.1951)

4'-ethenyl-2-hydroxy-3'-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4',4'a,5',5'a,7',8'-hexahydro-3'h-spiro[indole-3,6'-pyrano[3,4-f]indolizin]-10'-one

C26H30N2O9 (514.1951)

3-(4-hydroxy-3-methoxyphenyl)-n-[2-(5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h-indol-3-yl)ethyl]prop-2-enimidic acid

C26H30N2O9 (514.1951)

(3s,6s,7r,8r)-8-benzyl-3-(3-hydroxy-4-methoxypyridine-2-amido)-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl 2-methylpropanoate

C26H30N2O9 (514.1951)

8-benzyl-3-(3-hydroxy-4-methoxypyridine-2-amido)-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl 2-methylpropanoate

C26H30N2O9 (514.1951)

(3s,3's,4'r,4'as,5'ar)-4'-ethenyl-2-hydroxy-3'-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4',4'a,5',5'a,7',8'-hexahydro-3'h-spiro[indole-3,6'-pyrano[3,4-f]indolizin]-10'-one

C26H30N2O9 (514.1951)

(3r,3's,4's,4'as,5'ar)-4'-ethenyl-2-hydroxy-3'-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4',4'a,5',5'a,7',8'-hexahydro-3'h-spiro[indole-3,6'-pyrano[3,4-f]indolizin]-10'-one

C26H30N2O9 (514.1951)

(1r,18s,19r,20s)-19-ethenyl-7-hydroxy-18-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15-pentaen-14-one

(1r,18s,19r,20s)-19-ethenyl-7-hydroxy-18-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15-pentaen-14-one

C26H30N2O9 (514.1951)

(2e)-3-(4-hydroxy-3-methoxyphenyl)-n-[2-(5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h-indol-3-yl)ethyl]prop-2-enimidic acid

C26H30N2O9 (514.1951)

5-ethenyl-4-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,6-dihydro-4h-pyran-3-carboxylic acid

C26H30N2O9 (514.1951)

(3r,3'r,4's,4'ar,5'as)-4'-ethenyl-2-hydroxy-3'-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4',4'a,5',5'a,7',8'-hexahydro-3'h-spiro[indole-3,6'-pyrano[3,4-f]indolizin]-10'-one

C26H30N2O9 (514.1951)